AN LUONG

Mr. AN LUONG

Center for Molecular Biomedicine, University of Medicine and Pharmacy at Ho Chi Minh City
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Cancer Investigation
Verified
Journal Article
Closed access
HNHuu Thinh Nguyen
Huu Thinh Nguyen
DTDuc Huy Tran
Duc Huy Tran
QNQuoc Dat Ngo
Quoc Dat Ngo
HPHong-Anh Thi Pham
Hong-Anh Thi Pham
TTThanh-Truong Tran
Thanh-Truong Tran
HNHoai Nghia Nguyen
Hoai Nghia Nguyen
The identification and quantification of actionable mutations are critical for guiding targeted therapy and monitoring drug response in colorectal cancer. Liquid biopsy (LB) based on plasma cell-free DNA analysis has emerged as a non-invasive approach with many clinical advantages over conventional tissue sampling. Here, we developed a LB protocol using ultra-deep massive parallel sequencing and validated its clinical performance for detection and quantification of actionable mutations in three major driver genes (KRAS, NRAS and BRAF). The assay showed a 92% concordance for mutation detection between plasma and paired tissues and great reliability in quantification of variant allele frequency.

12 December 2020 in Cells
Verified
Journal Article
Open access
PDF file
AN LUONGAN LUONG
AN LUONG
HDHuy Q. Do
Huy Q. Do
PTPaola Tarchi
Paola Tarchi
DBDeborah Bonazza
Deborah Bonazza
CBCristina Bottin
Cristina Bottin
CSCaecilia Sukowati
Caecilia Sukowati
Epidemiology of hepatocellular carcinoma (HCC) showed a correlation between incidence and geographical-relevant risk factors. This study aims to compare the distributions of cancer stem cells (CSC) in two distant populations in Asia and Europe. We analyzed 52 and 43 selected HCC patients undergoing hepatectomy in Ho Chi Minh City (Vietnam) and Trieste (Italy). Each patient sample consisted of HCC, peri-HCC, and non-tumoral (distal) tissue. Demographic data were recorded together with clinical findings. The protocol for the collection of tissue samples and RNA was standardized in both laboratories and gene expression analysis was performed in a single laboratory with identical PCR conditions. Baseline data showed comparable laboratory findings between the two cohorts. mRNA distribution showed a comparable pattern of all CSC markers analyzed with the expression of CD90 progressively increasing from distal and peri-HCC to be highest in HCC (p < 0.001), confirmed by immunofluorescence data. CD90 mRNA distribution was related to HBV-related HCC and a tumor diameter less than 5 cm. Patients with high tumoral CD90 mRNA had a shorter time (p < 0.05) to tumor recurrence compared to patients with lower CD90. This comparative study showed that CD90 mRNA expressions are comparable between Eastern and Western HCC cases.

30 January 2018 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
HHHoang Bui Huu
Hoang Bui Huu
NTNhuong Ha Thuc
Nhuong Ha Thuc
HLHoa Pham Thi Le
Hoa Pham Thi Le
TTThuy Do Thi Thanh
Thuy Do Thi Thanh
AN LUONGAN LUONG
AN LUONG
GFGiorgio Fassina
Giorgio Fassina
Viral hepatitis infection is a major global issue and a leading cause of liver disease and associated deaths. Over time, patients infected with hepatitis B (HBV) or C virus (HCV) develop cirrhosis and, eventually, hepatocellular carcinoma (HCC). For this reason, they need to be constantly monitored. Current Asian guidelines recommend the determination of serum alpha-fetoprotein (AFP) together with liver ultrasounds every six months to detect HCC nodules. However, both methods have several limitations, and other biomarkers have been studied for monitoring cirrhosis, including SCCA-IgM, an immune-complex formed by Squamous Cell Carcinoma Antigen and IgM. To date, SCCA-IgM has been validated as a novel biomarker for liver diseases only in European populations. The aim of our study was to analyze SCCA-IgM as a biomarker to monitor cirrhosis evolution in an Asian cohort of patients and to compare its performance to that of AFP. We analyzed the concentration of AFP and SCCA-IgM in serum samples obtained from a group of Asian adult patients with cirrhosis or HCC and a control group of patients admitted for gastrointestinal disorders. In untreated patients and similarly to AFP, SCCA-IgM levels were significantly higher in patients with cirrhosis compared to those with HCC. In addition, SCCA-IgM, but not AFP serological levels, were significantly lower in HCC patients who were treated with surgical resection compared to those who received a different therapy.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Supplementary Table S1 summarizes RNA quality metrics for swab and tissue samples, sequencing quality statistics for swab samples (with and without bacterial rRNA depletion) as well as tissue samples, and gene detection profiles for paired samples, including counts of shared and tissue-specific genes across both global and OSCC-associated gene sets.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Supplementary Figure S4 - Gene expression concordance and overlap of HNSCC-Associated genes between swab and tissue samples. (A) Heatmap illustrates the Pearson correlation coefficients r of gene expression level, normalized to Transcript Per Million (TPM), across all samples, with color intensity representing the strength of correlation. (B) A Venn diagram shows the overlap of genes, with significant genes of HNSCC cancer in oncodb database, identified from both swab (n=39)(yellow) and tissue (n=39)(blue) samples.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Supplementary Figure S3 - Comparison of read mapping profiles and bacterial rRNA characterization in swab and tissue samples. (A) Stack bar plot illustrates the distribution of sequencing reads, showing the percentage of unmapped reads (red), uniquely mapped reads (green), and reads mapped to multiple sites (blue) to the human genome (hg38) from swab (without [No] (n=18) and with [Yes] (n=39) bacterial rRNA depletion) and tissue samples. (B) Mapping and OTU-picking read counts of non-depleted bacterial rRNA swabs (n=18) in Silva metatranscriptomic and metagenomic database.